Sun Pharmaceutical Industries Limited — Updates, 15-01-2026: Press Release
15-01-2026 | 10:57 pm
15-01-2026 | 10:57 pm
Sun Pharma launched UNLOXCYT in the U.S. for advanced Cutaneous Squamous Cell Carcinoma, offering a new treatment option. The drug combines durable efficacy with a proven tolerability profile, representing a key business development.
No comments yet. Be the first to comment!
All announcements from Sun Pharmaceutical Industries Limited
